Abstract
The trigeminal autonomic cephalalgias (TACs) can be considered a spectrum of headache disorders, which differs in attacks duration and frequency. Cluster headache on one end of the spectrum has the longest attack duration and the lowest frequency of attacks of the TACs. Paroxysmal hemicrania, SUNCT (short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing) and SUNA (short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms) on the other end of the spectrum are characterised by very short-lasting but extremely frequent headache attacks. Identifying these rarer forms of TACs is paramount in view of their different response to treatment compared to cluster headache.
This chapter will focus on the description of the epidemiological, clinical and treatment aspects of SUNCT and SUNA. Furthermore it will provide clinical insights on the differential diagnosis of the broad group of primary short-lasting headache disorders, including primary stabbing headache, hypnic headache, trigeminal neuralgia, primary cough headache, primary exercise headache, primary headache associated with cold stimulus, laughter-induced headache, and primary sexual headache.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.
Sjaastad O, Saunte C, Salvesen R, Fredriksen T, Seim A, Roe O, et al. Shortlasting, unilateral neuralgiform headache attacks with conjunctival injection, tearing, sweating, and rhinorrhea. Cephalalgia. 1989;9(2):147–56.
IHS Classification. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004;24(Suppl1):9–160.
Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38:1–211.. https://www.ichd-3.org/
Williams M, Broadley S. SUNCT and SUNA: clinical features and medical treatment. J Clin Neurosci. 2008;15(5):526–34.
Cohen A. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)—a prospective clinical study of SUNCT and SUNA. Brain. 2006;129(10):2746–60.
May A, Bahra A, Büchel C, Frackowiak R, Goadsby P. Hypothalamic activation in cluster headache attacks. Lancet. 1998;352(9124):275–8.
Cohen A. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing. Cephalalgia. 2007;27(7):824–32.
Matharu M, Cohen A, McGonigle D, Ward N, Frackowiak R, Goadsby P. Posterior hypothalamic and brainstem activation in hemicrania continua. Headache. 2004;44(8):747–61.
Matharu M, Cohen A, Frackowiak R, Goadsby P. Posterior hypothalamic activation in paroxysmal hemicrania. Ann Neurol. 2006;59(3):535–45.
Pareja J, Barón M, Gili P, Yangüela J, Caminero A, Dobato J, et al. Objective assessment of autonomic signs during triggered first division trigeminal neuralgia. Cephalalgia. 2002;22(4):251–5.
Sano K, Mayanagi Y, Sekino H, Ogashiwa M, Ishijima B. Results of stimulation and destruction of the posterior hypothalamus in man. J Neurosurg. 1970;33(6):689–707.
Lambru G, Trimboli M, Tan S, Al-Kaisy A. Medullary infarction causing coexistent SUNCT and trigeminal neuralgia. Cephalalgia. 2016;37(5):486–90.
Levy M, Matharu M, Meeran K, Powell M, Goadsby P. The clinical characteristics of headache in patients with pituitary tumours. Brain. 2005;128(8):1921–30.
Mitsikostas D, Ashina M, Craven A, Diener H, Goadsby P, Ferrari M, et al. European headache federation consensus on technical investigation for primary headache disorders. J Headache Pain. 2015;17:5.
May A, Leone M, Afra J, Linde M, Sándor PS, Evers S, Goadsby PJ. EFNS Task Force EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol. 2006;13(10):1066–77.
Matharu MS, Boes CJ, Goadsby PJ. SUNCT syndrome: prolonged attacks, refractoriness and response to topiramate. Neurology. 2002;58(8):1307.
Rossi P, Cesarino F, Faroni J, Malpezzi MG, Sandrini G, Nappi G. Sunct syndrome successfully treated with topiramate: case reports. Cephalalgia. 2003;23(10):998–1000.
Weng HY, Cohen AS, Schankin C, Goadsby PJ. Phenotypic and treatment outcome data on SUNCT and SUNA, including a randomised placebo-controlled trial. Cephalalgia. 2018;38(9):1554–63.
Ikawa N, Imai N, Manaka S. A case of SUNCT syndrome responsive to zonisamide. Cephalalgia. 2010;31(4):501–3.
Graff-Radford SB. SUNCT syndrome responsive to gabapentin (neurontin). Cephalalgia. 2000;20(5):515–7.
Hunt C, Dodick D, Bosch E. SUNCT responsive to gabapentin. Headache. 2002;42(6):525–6.
Porta-Etessam J, Benito-Leon J, Martinez-Salio A, Berbel A. Gabapentin in the treatment of SUNCT syndrome. Headache. 2002;42(6):523–4.
Matharu M, Cohen A, Boes C, Goadsby P. Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing syndrome: a review. Curr Pain Headache Rep. 2003;7(4):308–18.
Dora B. SUNCT syndrome with dramatic response to oxcarbazepine. Cephalalgia. 2006;26(9):1171–3.
Marziniak M, Breyer R, Evers S. SUNCT syndrome successfully treated with the combination of oxcarbazepine and gabapentin. Pain Med. 2009;10(8):1497–500.
Zabalza R. Sustained response to botulinum toxin in SUNCT syndrome. Cephalalgia. 2012;32(11):869–72.
Matharu M, Cohen A, Goadsby P. SUNCT syndrome responsive to intravenous lidocaine. Cephalalgia. 2004;24(11):985–92.
Pareja J, Caballero V, Sjaastad O. SUNCT syndrome. Status like pattern. Headache. 1996;36(10):622–4.
Raimondi E, Gardella L. SUNCT syndrome. Two cases in Argentina. Headache. 1998;38(5):369–71.
Maihöfner C, Speck V, Sperling W, Giede-Jeppe A. Complete remission of SUNCT syndrome by intravenous glucocorticoid treatment. Neurol Sci. 2012;34(10):1811–2.
Barker F, Jannetta P, Bissonette D, Larkins M, Jho H. The long-term outcome of microvascular decompression for trigeminal neuralgia. N Engl J Med. 1996;334(17):1077–84.
Gardella L, Viruega A, Rojas H, Nagel J. A case of a patient with SUNCT syndrome treated with Jannetta procedure. Cephalalgia. 2001;21(10):996–9.
Black D, Dodick D. Two cases of medically and surgically intractable Sunct: a reason for caution and an argument for a central mechanism. Cephalalgia. 2002;22(3):201–4.
Lagares A, Gómez P, Pérez-Nuñez A, Lobato R, Ramos A. Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing syndrome treated with microvascular decompression of the trigeminal nerve: case report. Neurosurgery. 2005;56(2):E413.
Sprenger T, Valet M, Platzer S, Pfaffenrath V, Steude U, Tolle T. SUNCT: bilateral hypothalamic activation during headache attacks and resolving of symptoms after trigeminal decompression. Pain. 2005;113(3):422–6.
Guerreiro R, Casimiro M, Lopes D, Marques J, Fontoura P. Video NeuroImage: symptomatic SUNCT syndrome cured after trigeminal neurovascular contact surgical decompression. Neurology. 2009;72(7):e37.
Irimia P, González-Redondo R, Domínguez P, Díez-Valle R, Martínez-Vila E. Microvascular decompression may be effective for refractory SUNCT regardless of symptom duration. Cephalalgia. 2009;30(5):626–30.
Williams M, Bazina R, Tan L, Rice H, Broadley S. Microvascular decompression of the trigeminal nerve in the treatment of SUNCT and SUNA. J Neurol Neurosurg Psychiatry. 2010;81(9):992–6.
Lambru G, Shanahan P, Watkins L, Matharu MS. Occipital nerve stimulation in the treatment of medically intractable SUNCT and SUNA. Pain Physician. 2014;17(1):29–41.
Miller S, Watkins L, Matharu M. Long-term follow up of intractable chronic short lasting unilateral neuralgiform headache disorders treated with occipital nerve stimulation. Cephalalgia. 2017;38(5):933–42.
Leone M, Franzini A, D'Andrea G, Broggi G, Casucci G, Bussone G. Deep brain stimulation to relieve drug-resistant SUNCT. Ann Neurol. 2005;57(6):924–7.
Lyons M, Dodick D, Evidente V. Responsiveness of short-lasting unilateral neuralgiform headache with conjunctival injection and tearing to hypothalamic deep brain stimulation. J Neurosurg. 2009;110(2):279–81.
Bartsch T, Falk D, Knudsen K, Reese R, Raethjen J, Mehdorn H, et al. Deep brain stimulation of the posterior hypothalamic area in intractable short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT). Cephalalgia. 2011;31(13):1405–8.
Miller S, Akram H, Lagrata S, Hariz M, Zrinzo L, Matharu M. Ventral tegmental area deep brain stimulation in refractory short-lasting unilateral neuralgiform headache attacks. Brain. 2016;139(10):2631–40.
Palmisani S, Al-Kaisy A, Arcioni R, Smith T, Negro A, Lambru G, et al. A six year retrospective review of occipital nerve stimulation practice—controversies and challenges of an emerging technique for treating refractory headache syndromes. J Headache Pain. 2013;14(1):67.
Holle D, Naegel S, Krebs S, Katsarava Z, Diener H, Gaul C, et al. Clinical characteristics and therapeutic options in hypnic headache. Cephalalgia. 2010;30(12):1435–42.
Raskin N. The hypnic headache syndrome. Headache. 1988;28(8):534–6.
Lanteri-Minet M, Donnet A. Hypnic headache. Curr Pain Headache Rep. 2010;14(4):309–15.
Lanteri-Minet M. Hypnic headache. Headache. 2014;54(9):1556–9.
Bahra A, May A, Goadsby P. Cluster headache: a prospective clinical study with diagnostic implications. Neurology. 2002;58(3):354–61.
Cittadini E, Matharu M, Goadsby P. Paroxysmal hemicrania: a prospective clinical study of 31 cases. Brain. 2008;131(4):1142–55.
Holle D, Naegel S, Obermann M. Hypnic headache. Cephalalgia. 2013;33(16):1349–57.
Holle D, Wessendorf T, Zaremba S, Naegel S, Diener H, Katsarava Z, et al. Serial polysomnography in hypnic headache. Cephalalgia. 2010;31(3):286–90.
Pinessi L, Rainero I, Cicolin A, Zibetti M, Gentile S, Mutani R. Hypnic headache syndrome: association of the attacks with rem sleep. Cephalalgia. 2003;23(2):150–4.
Naegel S, Huhn J, Gaul C, Diener H, Obermann M, Holle D. No pattern alteration in single nocturnal melatonin secretion in patients with hypnic headache: a case-control study. Headache. 2016;57(4):648–53.
Cohen A, Kaube H. Rare nocturnal headaches. Curr Opin Neurol. 2004;17(3):295–9.
Holle D, Naegel S, Krebs S, Gaul C, Gizewski E, Diener H, et al. Hypothalamic gray matter volume loss in hypnic headache. Ann Neurol. 2010;69(3):533–9.
Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G. Hypothalamic activation in spontaneous migraine attacks. Headache. 2007;47(10):1418–26.
Schulte L, Allers A, May A. Hypothalamus as a mediator of chronic migraine. Neurology. 2017;88(21):2011–6.
Cohen A. SUN: short-lasting unilateral neuralgiform headache attacks. Headache. 2017;57(6):1010–20.
Singh N, Sahota P. Sleep-related headache and its management. Curr Treat Options Neurol. 2013;15(6):704–22.
Diener H, Obermann M, Holle D. Hypnic headache: clinical course and treatment. Curr Treat Options Neurol. 2011;14(1):15–26.
Lisotto C, Rossi P, Tassorelli C, Ferrante E, Nappi G. Focus on therapy of hypnic headache. J Headache Pain. 2010;11(4):349–54.
Pareja J, Kruszewski P, Caminero A. SUNCT syndrome versus idiopathic stabbing headache (jabs and jolts syndrome). Cephalalgia. 1999;19(25_suppl):46–8.
Lane R, Davies P. Modified Valsalva test differentiates primary from secondary cough headache. J Headache Pain. 2013;14:31.
Sjaastad O, Bakketeig L. Exertional headache. I. Vågå study of headache epidemiology. Cephalalgia. 2002;22(10):784–90.
Sjaastad O, Bakketeig L. Exertional headache—II. Clinical features Vaga study of headache epidemiology. Cephalalgia. 2003;23(8):803–7.
Ran Y, Liu H, Zhang M, Dong Z, Yu S. Laugh-induced headache: clinical features and literature review. Headache. 2017;57(10):1498–506.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Cohen, A., Lambru, G. (2020). The Short-Lasting Headaches Including Hypnic Headache. In: Leone, M., May, A. (eds) Cluster Headache and other Trigeminal Autonomic Cephalgias. Headache. Springer, Cham. https://doi.org/10.1007/978-3-030-12438-0_18
Download citation
DOI: https://doi.org/10.1007/978-3-030-12438-0_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-12437-3
Online ISBN: 978-3-030-12438-0
eBook Packages: MedicineMedicine (R0)